Quality of life in patients suffering from toenail onychomycosis

J.C. Szepietowski,1 A. Reich,1 P. Pacan,2 E. Garlowska3 and E. Baran1

Author address: 

1Department of Dermatology, Venereology and Allergology, University of Medicine, Wroclaw, Poland, 2Department of Psychiatry, University of Medicine, Wroclaw, Poland and 3Novartis Poland, Warsaw, Poland

Abstract: 

Background: Onychomycosis is the most frequent nail disease, which could impair the patient’s quality of life. Objective: The presented study was undertaken to evaluate the impact of toenail onychomycosis on quality of life among Polish population. Material and methods: 3904 (2269 females and 1635 males) individuals fulfilled an international onychomycosis-specific quality of life questionnaire consisting of statements regarding social, emotional and symptoms problems. All patients had toenail onychomycosis confirmed by the positive direct microscopic examination and/or by the positive mycologic culture. 767 patients suffered simultaneously from fingernail onychomycosis. All patients were divided into subgroups according to sex, age, education level, place of living, type of onychomycosis, number of involved toenails, fingernails involvement, duration of illness and previously used antimycotic therapy. Results: Most of the patients demonstrated significantly reduced quality of life. The degree of life impairment varied between analyzed subgroups. Patients with more advanced toenail onychomycosis and with fingernail involvement were more seriously affected. Both social and emotional impairments were more pronounced in females than in males, although there were no differences according to symptoms. Moreover, patients with better education level and people living in towns or cities were more emotionally and socially affected by onychomycosis, although people living in the country or with poorer education level presented with significantly more severe symptoms. Conclusions: Toenail onychomycosis is still a serious medical problem, which can significantly reduce the patient’s quality of life.
2005

abstract No: 

P077

Full conference title: 

2nd Trends in Medical Mycology
    • TIMM 2nd (2010)